Morbidity and mortality of Serratia marcescens bacteraemia during the substance use epidemic

Ryan Bloom1, Kinna Thakarar2, Kristina E Rokas3

  • 1Tufts University School of Medicine, Boston, MA, USA.

Abstract

Insights

Outcomes for persons who inject drugs (PWID) with Serratia marcescens bacteraemia are similar to non-PWID. Despite being younger with fewer comorbidities, PWID have higher rates of infective endocarditis.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Public Health

Background:

  • Serratia marcescens is an environmental bacterium causing diverse infections.
  • Historically linked to persons who inject drugs (PWID), literature on this association is limited.
  • This study compares S. marcescens bacteraemia in PWID versus non-PWID.

Purpose of the Study:

  • To compare treatment characteristics and clinical outcomes of S. marcescens bacteraemia between PWID and non-PWID.
  • To identify differences in comorbidities, infection types, and treatment strategies.
  • To assess long-term mortality in these patient groups.

Main Methods:

  • Retrospective cohort study from 2013-2019 at a tertiary medical center.
  • Inclusion criteria: age ≥ 18 years with positive blood culture for S. marcescens.
  • Comparison of demographic, clinical, and outcome data between PWID and non-PWID.

Main Results:

  • 14 PWID (21%) and 53 non-PWID (79%) identified.
  • PWID were younger (median 32 vs. 67 years) with less renal disease (7% vs. 34%).
  • PWID had higher infective endocarditis (IE) rates (48% vs. 0%) and received more combination antimicrobial therapy (29% vs. 2%).
  • 12-month all-cause mortality was comparable (21% in both groups).

Conclusions:

  • Long-term outcomes for PWID with S. marcescens bacteraemia are comparable to non-PWID.
  • PWID represent a younger cohort with fewer comorbidities but higher IE incidence.
  • Clinicians should maintain high suspicion for IE in PWID presenting with S. marcescens bacteraemia.

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
269
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
17
Urinary Tract Infection II: Pathophysiology01:25

Urinary Tract Infection II: Pathophysiology

The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
19
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
201
Urine Studies II: Urine Culture and Sensitivity Test01:26

Urine Studies II: Urine Culture and Sensitivity Test

A urine culture and sensitivity test is a diagnostic procedure used to identify urinary tract bacterial infections and determine the most effective antibiotics for treatment. This test is generally preferred when a patient shows manifestations of a urinary tract infection, such as frequent or painful urination, cloudy or foul-smelling urine, or lower abdominal pain.Purpose of the TestThe primary goals of a urine culture and sensitivity test are to:Determine the specific bacteria causing the...
55